Effectiveness of treatment with nebulized colistin in patients with COPD

References

• KellyJLBamseyOSmithCHealth status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatientsRespiration201284319319922441322
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• MiravitllesMGarcía-PoloCDomenechAVillegasGCongetFde la RozaCClinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary diseaseLung2013191552353023842641
   PubMed Web of Science ®Google Scholar
• SethiSInfectious etiology of acute exacerbations of chronic bronchitisChest2000117380S385S10843981
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease. Identification of biologic clusters and their biomarkersAm J Respir Crit Care Med201118466267121680942
   PubMed Web of Science ®Google Scholar
• RosellAMonsoESolerNMicrobiologic determinants of exacerbation in chronic obstructive pulmonary diseaseArch Intern Med200516589189715851640
   PubMed Web of Science ®Google Scholar
• EllerJEdeASchabergTNiedermanMMauchHLodeHInfective exacerbation of chronic bronchitis. Relation between bacteriologic etiology and lung functionChest1998113154215489631791
   PubMed Web of Science ®Google Scholar
• LiebermanDLiebermanDPseudomonal infections in patients with COPD: epidemiology and managementAm J Respir Med20032645946814719985
   PubMedGoogle Scholar
• LodeHAlleweltMBalkSA prediction model for bacterial etiology in Acute Exacerbations of COPDInfection20073514314917565454
   PubMed Web of Science ®Google Scholar
• García-VidalCAlmagroPRomaníVPseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective studyEur Respir J2009341072107819386694
   PubMed Web of Science ®Google Scholar
• Martínez-GarcíaMASoler-CataluñaJJDonatYFactors associated with bronchiectasis in patients with COPDChest20111401130113721546440
   PubMed Web of Science ®Google Scholar
• GallegoMPomaresXEspasaMPseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factorsBMC Pulm Med20141410324964956
   PubMed Web of Science ®Google Scholar
• AlmagroPSalvadóMGarcia-VidalCPseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary diseaseRespiration2012841364321996555
   PubMed Web of Science ®Google Scholar
• MurphyTFPseudomonas aeruginosa in adults with chronic obstructive pulmonary diseaseCurr Opin Pulm Med200915213814219532029
   PubMed Web of Science ®Google Scholar
• RakhimovaEWiehlmannLBrauerALSethiSMurphyTFTümmlerBPseudomonas aeruginosa population biology in chronic obstructive pulmonary diseaseJ Infect Dis20092001928193519919307
   PubMed Web of Science ®Google Scholar
• Martínez-SolanoLMaciaMDFajardoAOliverAMartínezJLChronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary diseaseClin Infect Dis2008471526153318990062
   PubMed Web of Science ®Google Scholar
• ValderreyADPozueloMJJiménezPAMaciáMDOliverARotgerRChronic colonization by Pseudomonas aeruginosa of patients with obstructive lung disease: cystic fibrosis, bronchiectasis and chronic obstructive pulmonary diseaseDiagn Microbiol Infect Dis201068202720727465
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://goldcopd.orgAccessed February 4, 2017
   Google Scholar
• NaidichDPMcCauleyDIKhouriNFStitikFPSiegelmanSSComputed tomography of bronchiectasisJ Comput Assist Tomogr198264374447096687
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational SupplementWayne, PAClinical and Laboratory Standards Institute2010
   Google Scholar
• WilsonRSethiSAnzuetoAMiravitllesMAntibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary diseaseJ Infect201367649751523973659
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish Society of Pulmonology and Thoracic Surgery. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic SurgeryArch Bronconeumol20124824725722561012
   PubMed Web of Science ®Google Scholar
• FielSBAerosolized antibiotics in cystic fibrosis: an update. Fiel SBExpert Rev Respir Med20148330531424838090
   PubMed Web of Science ®Google Scholar
• AngrillJAgustiCde CelisRBacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factorsThorax200257151911809984
   PubMed Web of Science ®Google Scholar
• SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med20083592355236519038881
   PubMed Web of Science ®Google Scholar
• LoebingerMRWellsAUHansellDMMortality in bronchiectasis: a long-term study assessing the factors influencing survivalEur Respir J20093484384919357155
   PubMed Web of Science ®Google Scholar
• PasteurMCBiltonDHillATBritish Thoracic Society Bronchiectasis Non-CF Guideline GroupBritish Thoracic Society guideline for non-CF bronchiectasisThorax201065Suppl 1i1i5820627931
   PubMed Web of Science ®Google Scholar
• YangJWFanLCLuHWMiaoXYMaoBXuJFEfficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysisClin Respir J201610673173925620629
   PubMed Web of Science ®Google Scholar
• Dal NegroRMichelettoCTognellaSTobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammationAdv Ther2008251019103018821068
   PubMed Web of Science ®Google Scholar
• SteinfortDPSteinfortCEffect of long-term nebulised colistinon lung function and quality of life in patients with chronic bronchial sepsisIntern Med J20073749549817547727
   PubMed Web of Science ®Google Scholar
• ManuelMJMuñoz-EzquerreMLópez-SánchezMAdherencia y efectividad en el control de exacerbaciones en pacientes con EPOC grave bajo el tratamiento con colimicina inhalada (Promixin®) en dispositivo I-neb. [Adherence and effectiveness in the control of exacerbations in patients with severe COPD under treatment with inhaled colimicin (Promixin®) in an I-neb device]Arch Bronconeum46th National Congress Spanish Society of Pulmonology and Thoracic Surgery2012 [Abstract]. Spanish
   Google Scholar
• SethiSRennardSIMiravitllesMA Phase 2 study to evaluate the safety, tolerability and efficacy of levofloxacin inhalation solution (MP-376) administered for 5 days every 28 days to prevent acute exacerbations in high risk COPD patientsAm J Respir Crit Care Med2012185A3037
   Google Scholar
• AzoicaiDAntoniuSMP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infectionsExpert Opin Investig Drugs201322267e76
   Web of Science ®Google Scholar
• DrobnicMESuñéPMontoroJBFerrerAOrriolsRInhaled tobramycin in non–cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosaAnn Pharmacother200539394415562142
   PubMed Web of Science ®Google Scholar
• DharRAnwarGABourkeSCEfficacy of nebulised colomycin in patients with non–cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosaThorax201065553
   PubMed Web of Science ®Google Scholar
• MurrayMPGovanJRDohertyCJA randomized controlled trial of nebulised gentamicin in non–cystic fibrosis bronchiectasisAm J Respir Crit Care Med201118349149920870753
   PubMed Web of Science ®Google Scholar
• HarunNSSandersKStuart SteinfortCLong-term nebulised colistin aids sputum clearance of pseudomonas aeruginosa in adult non-cystic fibrosis bronchiectasisAm J Respir Crit Care Med2011183A4865
   Web of Science ®Google Scholar